Literature DB >> 3986770

Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas.

I Hellström, K E Hellström, N Rollins, V K Lee, K L Hudkins, G T Nepom.   

Abstract

Rats were immunized with cultured cells from chemically induced transitional cell carcinomas of the mouse urinary bladder, and their spleen cells were hybridized with NS-1 mouse myeloma cells. Following initial screening of antibodies made by hybridoma clones, the tissue distribution of antigens defined by the antibodies was established by using a peroxidase-antiperoxidase technique with frozen sections of a variety of mouse tumors, as well as normal adult and embryonic tissues. Two antibodies were identified which detected antigens with bladder carcinoma specificity. One antibody (3B12) reacted weakly with epithelial cells from several sources, including normal bladder, while the second antibody (6.10), which bound strongly to bladder carcinoma cells, was negative on bladder epithelium and bound (weakly) to only a small fraction of all epithelial cells tested except for epidermal cells and periosteum from embryos. Both antibodies should be useful to assess the immunotherapeutic and immunoprophylactic effects of monoclonal antibodies to tumor-type specific oncofetal antigens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986770

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  Effects of anti-idiotype vaccine on tumour growth and on production of soluble factors modulating cell-mediated immunity in vitro.

Authors:  J M Greer; W J Halliday
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity.

Authors:  V K Lee; T G Harriott; V K Kuchroo; W J Halliday; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.